Treatment of latent tuberculosis infection with short-course regimens in potential living kidney donors.
Jacques SimkinsChristian Donato-SantanaMichele Ileana MorrisLilian Margarita AbboJose Fernando CamargoShweta AnjanYoichiro NatoriGiselle GuerraPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
The time from QFT-GIT testing to donation was longer among QFT-GIT-positive donors. The short-course regimens appear to be excellent options for LTBI treatment among living kidney donors and avoid delaying organ donation further.